{
    "xml": "<topic id=\"PHP3345\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/co-fluampicil\" basename=\"co-fluampicil\" title=\"CO-FLUAMPICIL\">\n<title>CO-FLUAMPICIL</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_182\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/penicillins/flucloxacillin\">Flucloxacillin</xref>, <xref format=\"dita\" href=\"#bnf_int_185\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/penicillins/ampicillin\">Ampicillin</xref>\n</p>\n<data name=\"vtmid\">418084002</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_919205675\" title=\"Penicillins (broad-spectrum)\">Penicillins (broad-spectrum)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34546\" title=\"PENICILLINS\" namespace=\"/drug-classes/penicillins\">PENICILLINS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP56381\" outputclass=\"indicationsAndDose\" rev=\"1.37\" parent=\"/drugs/co-fluampicil\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Mixed infections involving beta-lactamase-producing staphylococci</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;9 years</p>\n<p>125/125&#8239;mg every 6&#8239;hours.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 10&#8211;17 years</p>\n<p>250/250&#8239;mg every 6&#8239;hours.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>250/250&#8239;mg every 6&#8239;hours.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection or by slow intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>250/250&#8239;mg every 6&#8239;hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Severe mixed infections involving beta-lactamase-producing staphylococci</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;9 years</p>\n<p>250/250&#8239;mg every 6&#8239;hours.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 10&#8211;17 years</p>\n<p>500/500&#8239;mg every 6&#8239;hours.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500/500&#8239;mg every 6&#8239;hours.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection or by slow intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500/500&#8239;mg every 6&#8239;hours.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56471\" outputclass=\"importantSafetyInformation\" rev=\"1.9\" parent=\"/drugs/co-fluampicil\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"title\">Hepatic disorders</p>\n<p>Cholestatic jaundice and hepatitis may occur very rarely, up to two months after treatment with flucloxacillin has been stopped. Administration for more than 2 weeks and increasing age are risk factors. Healthcare professionals are reminded that:</p>\n<ul>\n<li>flucloxacillin should not be used in patients with a history of hepatic dysfunction associated with flucloxacillin;</li>\n<li>flucloxacillin should be used with caution in patients with hepatic impairment;</li>\n<li>careful enquiry should be made about hypersensitivity reactions to beta-lactam antibacterials.</li>\n</ul>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56511\" outputclass=\"cautions\" rev=\"1.26\" parent=\"/drugs/co-fluampicil\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<title>General cautions:</title>\n<p>\n<ph outputclass=\"caution\">Acute lymphocytic leukaemia (increased risk of erythematous rashes)</ph>; <ph outputclass=\"caution\">chronic lymphocytic leukaemia (increased risk of erythematous rashes)</ph>; <ph outputclass=\"caution\">cytomegalovirus infection (increased risk of erythematous rashes)</ph>; <ph outputclass=\"caution\">glandular fever (erythematous rashes common)</ph>\n</p>\n<sectiondiv outputclass=\"additionalCautions\">\n<p outputclass=\"title\">Specific cautions:</p>\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"caution\">accumulation of electrolytes contained in parenteral preparations can occur with high doses</ph>; <ph outputclass=\"caution\">risk of kernicterus in jaundiced neonates when high doses given parenterally</ph> (in neonates)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56266\" outputclass=\"sideEffects\" rev=\"1.14\" parent=\"/drugs/co-fluampicil\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Gastro-intestinal disturbances</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Cholestatic jaundice</ph>; <ph outputclass=\"sideEffect\">hepatitis</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Rash</p>\n<p>If rash occurs, discontinue treatment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56331\" outputclass=\"pregnancy\" parent=\"/drugs/co-fluampicil\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Not known to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56532\" outputclass=\"breastFeeding\" parent=\"/drugs/co-fluampicil\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Trace amount in milk, but appropriate to use.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56401\" outputclass=\"hepaticImpairment\" parent=\"/drugs/co-fluampicil\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56287\" outputclass=\"renalImpairment\" parent=\"/drugs/co-fluampicil\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Reduce dose if eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>; rashes more common.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Reduce dose or frequency if estimated glomerular filtration rate less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>; rashes more common.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>Accumulation of electrolytes contained in parenteral preparations can occur in patients with renal failure.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56213\" outputclass=\"effectOnLaboratoryTests\" rev=\"1.8\" parent=\"/drugs/co-fluampicil\">\n<title>Effect on laboratory tests</title>\n<body>\n<section>\n<sectiondiv>\n<p>False-positive urinary glucose (if tested for reducing substances).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56562\" outputclass=\"directionsForAdministration\" rev=\"1.22\" parent=\"/drugs/co-fluampicil\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>intravenous infusion</i> (<i>Magnapen</i>\n<tm tmtype=\"reg\"/>), give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%. Reconstituted solutions diluted and given without delay; suggested volume 100&#8239;mL given over 30&#8211;60 minutes.</p>\n<p>\n<i>Via</i> drip tubing <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58012\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/co-fluampicil\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Dose expressed as a combination of equal parts by mass of flucloxacillin and ampicillin.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3345-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/co-fluampicil\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76315\" title=\"Capsule\" namespace=\"/drugs/co-fluampicil/capsule\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76345\" title=\"Oral suspension\" namespace=\"/drugs/co-fluampicil/oral-suspension\">Oral suspension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76338\" title=\"Powder for solution for injection\" namespace=\"/drugs/co-fluampicil/powder-for-solution-for-injection\">Powder for solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78502\" namespace=\"/treatment-summaries/penicillins\" title=\"Penicillins\" count=\"1\" rel=\"backlink\">Penicillins</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_182\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/penicillins/flucloxacillin\" title=\"Flucloxacillin\" count=\"1\" rel=\"link\">Flucloxacillin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_185\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/penicillins/ampicillin\" title=\"Ampicillin\" count=\"1\" rel=\"link\">Ampicillin</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34546\" namespace=\"/drug-classes/penicillins\" title=\"PENICILLINS\" count=\"1\" rel=\"link\">PENICILLINS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76315\" namespace=\"/drugs/co-fluampicil/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76345\" namespace=\"/drugs/co-fluampicil/oral-suspension\" title=\"Oral suspension\" count=\"1\" rel=\"link\">Oral suspension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76338\" namespace=\"/drugs/co-fluampicil/powder-for-solution-for-injection\" title=\"Powder for solution for injection\" count=\"1\" rel=\"link\">Powder for solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP3345",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/co-fluampicil",
    "basename": "co-fluampicil",
    "title": "CO-FLUAMPICIL",
    "interactants": [
        {
            "id": "bnf_int_182",
            "label": "Flucloxacillin"
        },
        {
            "id": "bnf_int_185",
            "label": "Ampicillin"
        }
    ],
    "vtmid": "418084002",
    "drugClassification": [
        "Penicillins (broad-spectrum)"
    ],
    "inheritsFromClass": [
        "PENICILLINS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Mixed infections involving beta-lactamase-producing staphylococci",
                        "html": "Mixed infections involving beta-lactamase-producing staphylococci"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection or slow intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By intramuscular injection or by slow intravenous injection or by intravenous infusion",
                    "html": "By intramuscular injection or by slow intravenous injection or by intravenous infusion"
                },
                "child": [
                    {
                        "textContent": "125/125 mg every 6 hours.",
                        "html": "<p>125/125&#8239;mg every 6&#8239;hours.</p>",
                        "ageGroup": "1 month&#8211;9 years"
                    },
                    {
                        "textContent": "250/250 mg every 6 hours.",
                        "html": "<p>250/250&#8239;mg every 6&#8239;hours.</p>",
                        "ageGroup": "10&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "250/250 mg every 6 hours.",
                        "html": "<p>250/250&#8239;mg every 6&#8239;hours.</p>"
                    },
                    {
                        "textContent": "250/250 mg every 6 hours.",
                        "html": "<p>250/250&#8239;mg every 6&#8239;hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Severe mixed infections involving beta-lactamase-producing staphylococci",
                        "html": "Severe mixed infections involving beta-lactamase-producing staphylococci"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection or slow intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By intramuscular injection or by slow intravenous injection or by intravenous infusion",
                    "html": "By intramuscular injection or by slow intravenous injection or by intravenous infusion"
                },
                "child": [
                    {
                        "textContent": "250/250 mg every 6 hours.",
                        "html": "<p>250/250&#8239;mg every 6&#8239;hours.</p>",
                        "ageGroup": "1 month&#8211;9 years"
                    },
                    {
                        "textContent": "500/500 mg every 6 hours.",
                        "html": "<p>500/500&#8239;mg every 6&#8239;hours.</p>",
                        "ageGroup": "10&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "500/500 mg every 6 hours.",
                        "html": "<p>500/500&#8239;mg every 6&#8239;hours.</p>"
                    },
                    {
                        "textContent": "500/500 mg every 6 hours.",
                        "html": "<p>500/500&#8239;mg every 6&#8239;hours.</p>"
                    }
                ]
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "title": "Hepatic disorders",
                "textContent": "Cholestatic jaundice and hepatitis may occur very rarely, up to two months after treatment with flucloxacillin has been stopped. Administration for more than 2 weeks and increasing age are risk factors. Healthcare professionals are reminded that:\n\nflucloxacillin should not be used in patients with a history of hepatic dysfunction associated with flucloxacillin; flucloxacillin should be used with caution in patients with hepatic impairment; careful enquiry should be made about hypersensitivity reactions to beta-lactam antibacterials.",
                "html": "<p>Cholestatic jaundice and hepatitis may occur very rarely, up to two months after treatment with flucloxacillin has been stopped. Administration for more than 2 weeks and increasing age are risk factors. Healthcare professionals are reminded that:</p><ul>\n<li>flucloxacillin should not be used in patients with a history of hepatic dysfunction associated with flucloxacillin;</li>\n<li>flucloxacillin should be used with caution in patients with hepatic impairment;</li>\n<li>careful enquiry should be made about hypersensitivity reactions to beta-lactam antibacterials.</li>\n</ul>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Acute lymphocytic leukaemia (increased risk of erythematous rashes)",
                "html": "Acute lymphocytic leukaemia (increased risk of erythematous rashes)"
            },
            {
                "type": "cautions",
                "textContent": "chronic lymphocytic leukaemia (increased risk of erythematous rashes)",
                "html": "chronic lymphocytic leukaemia (increased risk of erythematous rashes)"
            },
            {
                "type": "cautions",
                "textContent": "cytomegalovirus infection (increased risk of erythematous rashes)",
                "html": "cytomegalovirus infection (increased risk of erythematous rashes)"
            },
            {
                "type": "cautions",
                "textContent": "glandular fever (erythematous rashes common)",
                "html": "glandular fever (erythematous rashes common)"
            }
        ],
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "accumulation of electrolytes contained in parenteral preparations can occur with high doses",
                "html": "accumulation of electrolytes contained in parenteral preparations can occur with high doses",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ]
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "risk of kernicterus in jaundiced neonates when high doses given parenterally in neonates",
                "html": "risk of kernicterus in jaundiced neonates when high doses given parenterally in neonates",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ],
                    "patientType": "neonates"
                }
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Gastro-intestinal disturbances",
                        "html": "Gastro-intestinal disturbances",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Cholestatic jaundice",
                        "html": "Cholestatic jaundice",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hepatitis",
                        "html": "hepatitis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Rash",
                "textContent": "If rash occurs, discontinue treatment.",
                "html": "<p>If rash occurs, discontinue treatment.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Not known to be harmful.",
                "html": "<p>Not known to be harmful.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Trace amount in milk, but appropriate to use.",
                "html": "<p>Trace amount in milk, but appropriate to use.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution.",
                "html": "<p>Use with caution.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Reduce dose if eGFR less than 10 mL/minute/1.73 m2; rashes more common.",
                "html": "<p>Reduce dose if eGFR less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>; rashes more common.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Reduce dose or frequency if estimated glomerular filtration rate less than 10 mL/minute/1.73 m2; rashes more common.",
                "html": "<p>Reduce dose or frequency if estimated glomerular filtration rate less than 10&#8239;mL/minute/1.73&#8239;m<sup>2</sup>; rashes more common.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Accumulation of electrolytes contained in parenteral preparations can occur in patients with renal failure.",
                "html": "<p>Accumulation of electrolytes contained in parenteral preparations can occur in patients with renal failure.</p>"
            }
        ]
    },
    "effectOnLaboratoryTests": {
        "effectOnLaboratoryTests": [
            {
                "type": "effectOnLaboratoryTests",
                "textContent": "False-positive urinary glucose (if tested for reducing substances).",
                "html": "<p>False-positive urinary glucose (if tested for reducing substances).</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion (Magnapen ), give intermittently in Glucose 5% or Sodium chloride 0.9%. Reconstituted solutions diluted and given without delay; suggested volume 100 mL given over 30&#8211;60 minutes.\n\nVia drip tubing in Glucose 5% or Sodium chloride 0.9%.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Magnapen</i>\n<tm tmtype=\"reg\"/>), give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%. Reconstituted solutions diluted and given without delay; suggested volume 100&#8239;mL given over 30&#8211;60 minutes.</p><p>\n<i>Via</i> drip tubing <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Dose expressed as a combination of equal parts by mass of flucloxacillin and ampicillin.",
                "html": "<p>Dose expressed as a combination of equal parts by mass of flucloxacillin and ampicillin.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76315",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76345",
                "label": "Oral suspension",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76338",
                "label": "Powder for solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78502",
                "label": "Penicillins",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_182",
                "label": "Flucloxacillin",
                "type": "interaction"
            },
            {
                "id": "bnf_int_185",
                "label": "Ampicillin",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34546",
                "label": "PENICILLINS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76315",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76345",
                "label": "Oral suspension",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76338",
                "label": "Powder for solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}